Newlink Genetics reported $93.19M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 441.3M 24.65M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Capricor Therapeutics CAPR:US $ 64.92M 23.59M
Celldex Therapeutics CLDX:US $ 424.04M 20.61M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Idera Pharmaceuticals IDRA:US $ 30.13M 4.73M
Intrexon XON:US $ 335.57M 24.29M
Merk MRK:US $ 106668M 974M
Nektar Therapeutics NKTR:US $ 1024.12M 93.07M
Newlink Genetics NLNK:US $ 93.19M 7.12M
Prothena PRTA:US $ 581.41M 27.95M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Vascular Biogenics VBLT:US 56.29M 8.37M
YTE INCY:US $ 5054.22M 120.87M